Cerebrospinal fluid protein reactions during non-neurological surgery

Acta Neurologica Scandinavica

Volumn 115, Issue 4, 2007, Pages 254-259

  Anckarsater R ^a   Vasic, N ^a   Jideus L ^b   Kristiansson, M ^c   Zetterberg, H ^d   Blennow, K ^d   Anckarsater H ^e,f  

^a Kungalv Hospital   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e LUND UNIVERSITY   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Albumin; Beta 2 microglobuline; Blood brain barrier; Cerebrospinal fluid; Inflammation; Spinal anaesthesia; Stress

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; BIOCHEMICAL MARKER; BRAIN PROTEIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTERY CATHETER; ARTICLE; BLOOD ANALYSIS; BLOOD CEREBROSPINAL FLUID BARRIER; BLOOD SAMPLING; CEREBROSPINAL FLUID FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; KNEE ARTHROPLASTY; MALE; NEUROCHEMISTRY; PROTEIN CEREBROSPINAL FLUID LEVEL; SURGICAL PATIENT; SURGICAL STRESS;

AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, KNEE; BETA 2-MICROGLOBULIN; CEREBROSPINAL FLUID PROTEINS; FEMALE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; INTRAOPERATIVE PERIOD; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; SERUM ALBUMIN; STRESS;

EID: 33947391218     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00741.x     Document Type: Article

References (22)

1. TARKKILA PJ, KAUKINEN S. Complications during spinal anesthesia: a prospective study. Reg Anesth 1991;16:101-6.
2. SEGAL MB. The choroid plexuses and the barriers between the blood and the cerebrospinal fluid. Cell Mol Neurobiol 2000;20:183-96.
3. HIRAOKA A, ARATO T, TOMINAGA I, ANJYO A. Capillary electrophoretic analyses of beta-trace protein and other low molecular weight proteins in cerebrospinal fluid from patients with central nervous system diseases. J Pharm Biomed Anal 1997;15:1257-63.
4. URADE Y, KITAHAMA K, OHISHI H, KANEKO T, MIZUNO N, HAYAISHI O. Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc Natl Acad Sci U S A 1993;90:9070-4.
5. BLODORN B, BRUCK W, TUMANI H et al. Expression of the beta-trace protein in human pachymeninx as revealed by in situ hybridization and immunocytochemistry. J Neurosci Res 1999;57:730-4.
6. WATANABE K, URADE Y, MADER M, MURPHY C, HAYAISHI O. Identification of beta-trace as prostaglandin D synthase. Biochem Biophys Res Commun 1994;203:1110-6.
7. TANAKA T, URADE Y, KIMURA H, EGUCHI N, NISHIKAWA A, HAYAISHI O. Lipocalin-type prostaglandin D synthase (beta-trace) is a newly recognized type of retinoid transporter. J Biol Chem 1997;272:15789-95.
8. ARRER E, MECO C, OBERASCHER G, PIOTROWSKI W, ALBEGGER K, PATSCH W. beta-Trace protein as a marker for cerebrospinal fluid rhinorrhea. Clin Chem 2002;48:939-41.
9. STARMANS JJ, VOS J, VAN DER HELM HJ. The beta 2-microglobulin content of the cerebrospinal fluid in neurological disease. J Neurol Sci 1977;33:45-9.
10. IBSEN KK. beta 2-Microglobulin in cerebrospinal fluid from children with different diseases. Acta Paediatr Scand 1980;69:633-5.
11. MAVLIGHT GM, STUCKEY SE, CABANILLAS FF et al. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination. N Engl J Med 1980;303:718-22.
12. LAZZARIN A, CASTAGNA A, CAVALLI G et al. Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement. J Clin Lab Immunol 1992;38:175-86.
13. TIBBLING G, LINK H, OHMAN S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977;37:385-90.
14. BLENNOW K, FREDMAN P, WALLIN A et al. Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur Neurol 1993;33:129-33.
15. RAPOPORT S. Pathological alterations in the blood-brain barrier. In: Rapoport S, ed. Blood-brain barrier in physiology and medicine. New York: Raven Press, 1976;131-3.
16. AXELSSON R, MARTENSSON E, ALLING C. Impairment of the blood-brain barrier as an aetiological factor in paranoid psychosis. Br J Psychiatry 1982;141:273-81.
17. BAUER K, KORNHUBER J. Blood-cerebrospinal fluid barrier in schizophrenic patients. Eur Arch Psychiatry Neurol Sci 1987;236:257- 9.
18. BAYARD-BURFIELD L, ALLING C, BLENNOW K, JONSSON S, TRASKMAN-BENDZ L. Impairment of the blood-CSF barrier in suicide attempters. Eur Neuropsychopharmacol 1996;6:195-9.
19. ANCKARSATER H, FORSMAN A, BLENNOW K. Increased CSF/serum albumin ratio: a recurrent finding in violent offenders. Acta Neurol Scand 2005;112:48-50.
20. ABBOTT NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol 2000;20:131-47.
21. DE VRIES J, THIJSSEN WA, SNELS SE, MENOVSKY T, PEER NG, LAMERS KJ. Intraoperative values of S-100 protein, myelin basic protein, lactate, and albumin in the CSF and serum of neurosurgical patients. J Neurol Neurosurg Psychiatry 2001;71:671-4.
22. EDSBAGGE M, TISELL M, JACOBSSON L, WIKKELSO C. Spinal CSF absorption in healthy individuals. Am J Physiol Regul Integr Comp Physiol 2004;287:R1450-5.